These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7903983)

  • 1. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms.
    Haapasalo HK; Sallinen PK; Helén PT; Rantala IS; Helin HJ; Isola JJ
    J Pathol; 1993 Nov; 171(3):207-14. PubMed ID: 7903983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
    Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
    J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of PCNA labeling index in astrocytic tumors].
    Beppu T; Arai H; Kanaya H; Sasaki K
    No Shinkei Geka; 1992 Dec; 20(12):1255-9. PubMed ID: 1362456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic analysis of astrocytic gliomas correlating histological parameters with the proliferating cell nuclear antigen labelling index (PCNA-LI).
    Cruz-Sánchez FF; Ferreres JC; Figols J; Palacin A; Cardesa A; Rossi ML; Val-Bernal JF
    Histol Histopathol; 1997 Jan; 12(1):43-9. PubMed ID: 9046042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
    Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
    J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme.
    Karkavelas G; Mavropoulou S; Fountzilas G; Christoforidou V; Karavelis A; Foroglou G; Papadimitriou C
    Anticancer Res; 1995; 15(2):531-6. PubMed ID: 7763035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
    Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
    Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
    Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
    J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
    Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
    BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.
    Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C
    J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
    Grunnet ML; O'Neill A; Gilbert M; Hellman R
    Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.